Product Information
ATORVASTATIN 20 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0285 per EA under NDC 31722042590. Its NADAC has been published 112 times since May 8, 2024.
Strength
20 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722042590
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214344On Market Since
9/12/2023
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 20 MG TABLET has been published 112 times since May 8, 2024, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0285 per EA |
|---|---|
| All-time high | $0.0398 (Sep 11, 2024) |
| All-time low | $0.0277 (Nov 20, 2024) |
| 52-week high | $0.0354 |
| 52-week low | $0.0285 |
| Median price | $0.0319 |
| Average price | $0.0327 |
| Largest weekly change | +32.4% (Aug 21, 2024) |
| Weeks tracked | 112 |
| Tracking since | May 8, 2024 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0285 per EA (NDC 31722042590), effective Jun 24, 2026.
How has the price of ATORVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 16.0%. It has been tracked across 112 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?
Since May 8, 2024, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0277 (Nov 20, 2024) to a high of $0.0398 (Sep 11, 2024), with a median of $0.0319 per EA.
Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?
10 NADAC-published products share the same active ingredient, strength, and dosage form as ATORVASTATIN 20 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 20 MG TABLET?
ATORVASTATIN 20 MG TABLET (NDC 31722042590) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification